A Bad Judicial Decision Undercuts Drug Safety Law

zyrem.jpg

"I’m as big a fan of the 1st Amendment as anyone, but this decision strikes me as fundamentally flawed.  We’re not talking about a right to express yourself. We’re talking about selling stuff — stuff that could harm or even kill you if used improperly."  David Lazarus, LA Times Continue reading →

Safety Issues: FDA Scientists Collide with FDA Managers

Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs.

Continue reading →

FDA Scientists Collide with FDA Managers Re: Safety Issues

Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs. Continue reading →

Unexamined Drug Epidemic–the Elephant No One Wants to See

us_troops.jpg

“Prescription drug therapy stands as one of the most significant perils to health resulting from human activity.” What’s the FDA doing to stem the tide of this preventable epidemic? Continue reading →

Vicissitudes of Psychiatry’s Diagnostic Manual Revisions

The latest area of controversy focuses on the proposed revision of the definition "behavioral addiction disorder" extending the addiction diagnosis to include drug, alcohol and gambling.  It is estimated that the change would expand the number of people labeled as "addicts" by 20 to 30 million who would be entitled to treatment and disability payments costing taxpayers many hundreds of millions of dollars. Continue reading →

NIMH Scientist Charged with Criminal Conflict of Interest

CORRECTION: An Associated Press article about a federal criminal case accusing Dr. P. Trey Sunderland III of improperly accepting consulting fees from a drug maker, misstated the level of the charge against him. Dr. Sunderland was charged with "non-willful" criminal violation, a misdemeanor which carries a maximum one year prison term and $100,000 fine. It is NOT a felony, which is punishable by more than one year prison term.

Continue reading →

Marketing Trumps Safety: the case of Antipsychotics

"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale. Continue reading →